Wells Fargo’s Cytek Biosciences CTKB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $257K | Buy |
75,451
+3,963
| +6% | +$13.5K | ﹤0.01% | 4237 |
|
|
2025
Q1 | $287K | Buy |
71,488
+248
| +0.3% | +$994 | ﹤0.01% | 4024 |
|
|
2024
Q4 | $462K | Buy |
71,240
+15,516
| +28% | +$101K | ﹤0.01% | 3766 |
|
|
2024
Q3 | $309K | Buy |
55,724
+2,394
| +4% | +$13.3K | ﹤0.01% | 3917 |
|
|
2024
Q2 | $298K | Buy |
53,330
+17,189
| +48% | +$95.9K | ﹤0.01% | 3896 |
|
|
2024
Q1 | $243K | Buy |
36,141
+4,846
| +15% | +$32.5K | ﹤0.01% | 3992 |
|
|
2023
Q4 | $285K | Buy |
31,295
+7,021
| +29% | +$64K | ﹤0.01% | 3874 |
|
|
2023
Q3 | $134K | Sell |
24,274
-30,611
| -56% | -$169K | ﹤0.01% | 4275 |
|
|
2023
Q2 | $469K | Buy |
54,885
+32,800
| +149% | +$280K | ﹤0.01% | 3783 |
|
|
2023
Q1 | $203K | Buy |
22,085
+20,995
| +1,926% | +$193K | ﹤0.01% | 4155 |
|
|
2022
Q4 | $11.1K | Sell |
1,090
-763
| -41% | -$7.79K | ﹤0.01% | 5184 |
|
|
2022
Q3 | $27K | Sell |
1,853
-692
| -27% | -$10.1K | ﹤0.01% | 4927 |
|
|
2022
Q2 | $27K | Sell |
2,545
-35,806
| -93% | -$380K | ﹤0.01% | 5010 |
|
|
2022
Q1 | $413K | Buy |
38,351
+12,930
| +51% | +$139K | ﹤0.01% | 4272 |
|
|
2021
Q4 | $415K | Buy |
25,421
+25,340
| +31,284% | +$414K | ﹤0.01% | 4482 |
|
|
2021
Q3 | $2K | Buy |
+81
| New | +$2K | ﹤0.01% | 6226 |
|